Accretion Nutraveda Share Price Today | Stock Price & Accretion Nutraveda Share Screener

Track the current stock price of Accretion Nutraveda with an interactive chart. Analyse ANL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Accretion Nutraveda stock quote in one place.

Screen Accretion Nutraveda company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE1KVQ01019.

Classification

Identifiers and Leadership

Screen ANL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹42, up from ₹11 in 2025.

Latest statistics put total assets at ₹42 and shareholder funds at ₹36, with a leverage ratio of 0.20.

Screen Accretion Nutraveda income statement and profit fundamentals. Analyze ANL quarterly results. Accretion Nutraveda reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹34 and net profit of ₹5.

Screen ANL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹9, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹15 and financing activities provided ₹25.

See Accretion Nutraveda shareholding pattern with promoter, FII, and DII holdings. Check Accretion Nutraveda promoter holding and ownership changes for ANL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jan, promoters held 100.00%, foreign institutions 0.00%, domestic institutions 0.00% and the public 0.00%, spread across 10 shareholders.

The shareholder count was 10 in 2026-Jan, compared with 407 in 2026-Feb.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Accretion Nutraveda. Accretion Nutraveda dividend yield can be compared with peers and other stocks in the market.

See which indices include Accretion Nutraveda stock. Check ANL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Accretion Nutraveda corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Accretion Nutraveda stock events that may affect ANL share price, along with derivatives, futures and options activity and sector gainers.

2 corporate actions are listed, the most recent entry being Annual General Meeting dated August 27, 2026, with a record date of August 27, 2026.

Screen ANL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen ANL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated September 10, 2026 and September 9, 2026.

Key statistics were last updated on October 5, 2026. This page covers 4 balance sheet periods, 5 income statement periods, 4 cash flow years and 5 shareholding periods. Information is provided for research and is not investment advice.